Health Economics, Epidemiology, & Science Policy

Modeling

Models are a simplified description of a complex process. It is a framework for analyses which helps clarify the consequences of using a drug, device or procedure. They can be used to address a number of research problems, including:

Understanding the full implication of clinical trials
Generalizing the outcomes of clinical trials
Demonstrating the value of a product beyond its efficacy
Assess pricing scenarios
Trial planning
Strategic planning
Risk/Benefit assessments

North America:

United BioSource Corporation
7101 Wisconsin Avenue
Suite 600
Bethesda, Maryland 20814
Tel: +1 301 654 9729
Fax: +1 301 654 9864
analytics@
unitedbiosource.com

United BioSource Corporation
185 Dorval Avenue
Suite 500
Montreal, Quebec H9S 5J9
Canada
Tel: +1 514.422.8271
Fax: +1 514.422.8272
analytics@
unitedbiosource.com

Europe:

United BioSource Corporation
20 Bloomsbury Square
London WC1A 2NS
United Kingdom
Tel: +44 207 299 4550
Fax: +44 207 299 4555
analytics@
unitedbiosource.com

L. Clark Paramore, MSPH
Executive Director and Managing Director, Health Care Analytics - Boston
Bio Email

Ruth Brown, MS, MHSA
Director, Health Care Analytics - Europe
Senior Research Scientist
Bio Email

Bryan R. Luce, PhD, MBA
Senior Research Leader
Senior Vice President, Science Policy
United BioSource Corporation
Bio Email

Lynn J. Okamoto, PharmD
General Manager,
Health Care Analytics
Bio Email

Nancy Kline Leidy, PhD
Senior Vice President,
Scientific Affairs
Bio Email

J. Jaime Caro,
MDCM, FRCPC, FACP
Senior Vice President,
Health Economics
Email

Primer on Bayesian Statistics in Health Economics and Outcomes Research

Value of Investment in Health Care

For the citation reference for the Value of Investment publications, please contact analytics@
unitedbiosource.com.